Literature DB >> 7506394

The role of nitric oxide (NO) in 5-HT-induced relaxations of the guinea-pig stomach.

A L Meulemans1, L F Helsen, J A Schuurkes.   

Abstract

In a previous study we showed that the relaxations induced after vagal stimulation of the guinea-pig stomach are mediated via nitric oxide (NO) or a NO-related substance. Intra-arterial injection (i.a.) of 5-hydroxytryptamine (5-HT) also induced relaxations in the guinea-pig stomach. Since it has been shown that in the guinea-pig colon 5-HT-induced relaxations are mediated via NO the aim of this study was to establish whether NO is involved in the 5-HT-induced relaxations in the guinea-pig stomach. Intra-arterial injection of 5-HT induced dose-dependent relaxations of the stomach. Since atropine and alpha- and beta-adrenoceptor blocking agents did not influence the relaxation and since tetrodotoxin (TTX) blocked the relaxations, this effect is mediated via NANC-neurons. Administration of a NO-synthase-inhibitor NG-nitro-L-arginine (L-NNA) concentration-dependently reduced the 5-HT-induced relaxations. Haemoglobin (a NO-scavanger) did not affect the relaxations to 5-HT, while addition of methylene blue, an inhibitor of soluble guanylate cyclase, reduced the relaxations by 50%. Addition of an opioid receptor agonist (loperamide), a 5-HT1 antagonist (methiothepin or metergoline) or a 5-HT4 receptor agonist (cisapride) or -antagonist (tropisetron in micromolar concentrations) inhibited the 5-HT-induced relaxations. Neither the 5-HT4 receptor agonist renzapride, nor the novel 5-HT4 receptor antagonist SDZ 205-557, affected the relaxations to 5-HT.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7506394     DOI: 10.1007/bf00171343

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  36 in total

1.  Nature of the vagal inhibitory innervation to the lower esophageal sphincter.

Authors:  R K Goyal; S Rattan
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

Review 2.  The non-adrenergic non-cholinergic nervous system.

Authors:  G Burnstock
Journal:  Arch Int Pharmacodyn Ther       Date:  1986-04

3.  Inhibition of dopamine receptors in the stomach: an explanation of the gastrokinetic properties of domperidone.

Authors:  J M Van Nueten; C Ennis; L Helsen; P M Laduron; P A Janssen
Journal:  Life Sci       Date:  1978-08-07       Impact factor: 5.037

4.  The sites of action of 5-hydroxytryptamine in nerve-muscle preparations from the guinea-pig small intestine and colon.

Authors:  M Costa; J B Furness
Journal:  Br J Pharmacol       Date:  1979-02       Impact factor: 8.739

5.  Influence of NG-nitro-L-arginine methyl ester on vagally induced gastric relaxation in the anaesthetized rat.

Authors:  R A Lefebvre; J Hasrat; A Gobert
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

6.  Role of NO in vagally-mediated relaxations of guinea-pig stomach.

Authors:  A L Meulemans; L F Helsen; J A Schuurkes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

7.  Vascular endothelial cells synthesize nitric oxide from L-arginine.

Authors:  R M Palmer; D S Ashton; S Moncada
Journal:  Nature       Date:  1988-06-16       Impact factor: 49.962

8.  Role of nitric oxide as a mediator of internal anal sphincter relaxation.

Authors:  S Rattan; S Chakder
Journal:  Am J Physiol       Date:  1992-01

9.  Effect of NG-monomethyl L-arginine (L-NMMA) and NG-nitro L-arginine (L-NOARG) on non-adrenergic non-cholinergic relaxation in the circular muscle of the human ileum.

Authors:  C A Maggi; G Barbanti; D Turini; S Giuliani
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

10.  Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter.

Authors:  H Bult; G E Boeckxstaens; P A Pelckmans; F H Jordaens; Y M Van Maercke; A G Herman
Journal:  Nature       Date:  1990-05-24       Impact factor: 49.962

View more
  12 in total

1.  Smooth muscle 5-HT2A receptors mediating contraction of porcine isolated proximal stomach strips.

Authors:  P Janssen; N H Prins; A L Meulemans; R A Lefebvre
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

2.  Functional Dyspepsia: Impaired Fundic Accommodation.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-08

Review 3.  Serotonergic modulating drugs for functional gastrointestinal diseases.

Authors:  Robin Spiller
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

Review 4.  Pharmacology of serotonin: what a clinician should know.

Authors:  F De Ponti
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

5.  Subpopulations of gastric myenteric neurons are differentially activated via distinct serotonin receptors: projection, neurochemical coding, and functional implications.

Authors:  K Michel; H Sann; C Schaaf; M Schemann
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

Review 6.  Causes and treatment of functional dyspepsia.

Authors:  J Tack; R Bisschops; B DeMarchi
Journal:  Curr Gastroenterol Rep       Date:  2001-12

7.  Efficacy of mosapride citrate in proximal gastric accommodation and gastrointestinal motility in healthy volunteers: a double-blind placebo-controlled ultrasonographic study.

Authors:  Hiroaki Kusunoki; Ken Haruma; Jiro Hata; Tomoari Kamada; Manabu Ishii; Naohito Yamashita; Kazuhiko Inoue; Hiroshi Imamura; Noriaki Manabe; Akiko Shiotani
Journal:  J Gastroenterol       Date:  2010-07-24       Impact factor: 7.527

8.  Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man.

Authors:  J Tack; B Coulie; A Wilmer; A Andrioli; J Janssens
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

Review 9.  Impaired gastric accommodation and its role in dyspepsia.

Authors:  S Kindt; J Tack
Journal:  Gut       Date:  2006-07-19       Impact factor: 23.059

10.  Proximal Gastric Dysfunction in Functional Dyspepsia: Management Options.

Authors:  Jan Tack
Journal:  Curr Treat Options Gastroenterol       Date:  2004-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.